繁體
  • 简体中文
  • 繁體中文

熱門資訊> 正文

ProMIS Neurosciences通过ATM发行和PIPE融资筹集320万美元

2025-07-22 19:33

  • ProMIS Neurosciences (NASDAQ:PMN) has raised $0.8 million at-the-market from an existing healthcare-focused institutional investor.
  • The company entered into a definitive agreement for the issuance and sale of pre-funded warrants to purchase 984,736 common shares. The pre-funded warrants were sold at a price of $0.8124 per share.
  • In addition, the company has entered into a purchase agreement with an existing investor to sell approximately $2.4M of warrants at a price of $0.1875 per share through a private investment in public equity financing.
  • ProMIS plans to use the net proceeds from these offerings to further advance the clinical development of its lead therapeutic candidate, PMN310, as well as for working capital and other general corporate expenses.

風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。